Opus Genetics, Inc. (IRD) Tops Q2 EPS by 2c

Opus Genetics, Inc. (NASDAQ: IRD) reported Q2 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Opus Genetics, Inc. (IRD) click here.

You May Also Be Interested In

• JPMorgan upgrades Kraft Heinz credit to Overweight on deleveraging outlook
• Loar Holdings Inc. (LOAR) Reports Q2 EPS of $0.38 ; Offers Guidance
• Sonoma Pharmaceuticals (SNOA) Tops Q1 EPS by 21c